Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Daniel Weintraub, Eugenia Mamikonyan
American Journal of Geriatric Psychiatry (2019) Vol. 27, Iss. 9, pp. 998-1018
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies
Mir Hilal Ahmad, M. Moshahid A. Rizvi, Mansoor Ali, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101840-101840
Closed Access | Times Cited: 57
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Jessica R. Cohen, Annette Mathew, Kirk D. Dourvetakis, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 511-511
Open Access | Times Cited: 28
Telephone-based cognitive behavioral therapy for depression in Parkinson disease
Roseanne D. Dobkin, Sarah Mann, Michael A. Gara, et al.
Neurology (2020) Vol. 94, Iss. 16
Open Access | Times Cited: 97
Apathy in Parkinson’s Disease: Clinical Patterns and Neurobiological Basis
Matthieu Béreau, Vincent Van Waes, Mathieu Servant, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1599-1599
Open Access | Times Cited: 23
Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing
Nienke Mekkes, Minke Groot, Eric Hoekstra, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 1143-1153
Open Access | Times Cited: 13
Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease
Gianpaolo Maggi, Francis Loayza, Carmine Vitale, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2798-2809
Open Access | Times Cited: 8
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
Daniel Weintraub, Chelsea Caspell‐Garcia, Tanya Simuni, et al.
Annals of Clinical and Translational Neurology (2020) Vol. 7, Iss. 4, pp. 449-461
Open Access | Times Cited: 64
The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease
Akihisa Mori, Jiang‐Fan Chen, Shinichi Uchida, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2366-2366
Open Access | Times Cited: 36
Parkinson and depression: review and outlook
Gerd Laux
Journal of Neural Transmission (2022) Vol. 129, Iss. 5-6, pp. 601-608
Closed Access | Times Cited: 30
Small but Mighty—Exosomes, Novel Intercellular Messengers in Neurodegeneration
Meena Kumari, Antje Anji
Biology (2022) Vol. 11, Iss. 3, pp. 413-413
Open Access | Times Cited: 28
Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders
Javier Pagonabarraga, Cecilio Álamo, Mar Castellanos, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 318-318
Open Access | Times Cited: 20
Mild Behavioral Impairment in Parkinson’s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects
Efthalia Angelopoulou, Anastasia Bougea, Alexandros Hatzimanolis, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 115-115
Open Access | Times Cited: 7
Pilot Study of the International Parkinson and Movement Disorder Society‐sponsored Non‐motor Rating Scale (MDS‐NMS)
Pablo Martínez‐Martín, Anette Schrag, Daniel Weintraub, et al.
Movement Disorders Clinical Practice (2019) Vol. 6, Iss. 3, pp. 227-234
Open Access | Times Cited: 43
The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson’s disease
T. Celeste Napier, Alana Kirby, Amanda L. Persons
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 102, pp. 109942-109942
Closed Access | Times Cited: 42
Depression and anxiety among patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life
Eman M. Khedr, Ahmed A. Abdelrahman, Yasser Elserogy, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2020) Vol. 56, Iss. 1
Open Access | Times Cited: 41
Changing Gears – DBS For Dopaminergic Desensitization in Parkinson's Disease?
Daniel Weiß, Jens Volkmann, Alfonso Fasano, et al.
Annals of Neurology (2021) Vol. 90, Iss. 5, pp. 699-710
Closed Access | Times Cited: 39
Increased Risk of Parkinson's Disease in Patients With Schizophrenia Spectrum Disorders
Tomi Kuusimäki, Haidar Al‐Abdulrasul, Samu Kurki, et al.
Movement Disorders (2021) Vol. 36, Iss. 6, pp. 1353-1361
Open Access | Times Cited: 37
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic
Elisa Montanaro, Carlo Alberto Artusi, Cristina Rosano, et al.
Neurological Sciences (2021) Vol. 43, Iss. 1, pp. 341-348
Open Access | Times Cited: 37
Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment
Roseanne D. Dobkin, Sarah Mann, Daniel Weintraub, et al.
Movement Disorders (2021) Vol. 36, Iss. 11, pp. 2549-2558
Closed Access | Times Cited: 35
Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT 1A Agonist, in Patients With Parkinson Disease Psychosis
Stuart Isaacson, Larry B. Goldstein, Rajesh Pahwa, et al.
Neurology Clinical Practice (2023) Vol. 13, Iss. 4
Open Access | Times Cited: 15
The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics
Marco Onofrj, Mirella Russo, Stefano Delli Pizzi, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Drug-Induced Gambling Disorder: Epidemiology, Neurobiology, and Management
Mirjam Wolfschlag, Anders Håkansson
Pharmaceutical Medicine (2023) Vol. 37, Iss. 1, pp. 37-52
Open Access | Times Cited: 13
Artificial intelligence-based clustering and characterization of Parkinson's disease trajectories
Colin Birkenbihl, Ashar Ahmad, Nathalie J. Massat, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Behavior
Mark Hallett
Cambridge University Press eBooks (2025), pp. 5-10
Closed Access
Identification of Cognitive Training for Individuals with Parkinson’s Disease: A Systematic Review
Marina Francesca Gattoni, Silvia Gobbo, Sarah Feroldi, et al.
Brain Sciences (2025) Vol. 15, Iss. 1, pp. 61-61
Open Access
Page 1 - Next Page

Scroll to top